Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc.

World Rank (Aug-2026)
4757
Market Cap (Aug-2026)
3.292 Billion USD
Market Cap (Mar-08-2026)
2.977 Billion USD
World Rank (Jan-05-2024)
14,287
Market Cap (Jan-05-2024)
0.381 Billion USD
World Rank (Jul-30-2023)
10,942
Market Cap (Jul-30-2023)
0.667 Billion USD
World Rank (Jan-07-2022)
9,768
Market Cap (Jan-07-2022)
0.939 Billion USD
World Rank (Jan-01-2021)
7,129
Market Cap (Jan-01-2021)
1.227 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
ARQT
Employee Count
147
Employee Count as of Date
As on 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
372 Million USD
Annual Operating Income in USD
-12 Million USD
Annual Net Income in USD
-16 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
433 Million USD
Total Liabilities in USD
243 Million USD
Total Equity in USD
189 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
ARCUTIS BIOTHERAPEUTICS, INC.
Yahoo
Yahoo @ Nasdaq
Company Profile
Arcutis Biotherapeutics is a Pioneering Medical Dermatology company dedicated to revolutionizing the treatment of serious skin diseases. It is focused on filling the innovation gap in medical dermatology drug development by applying deep clinical, product development and commercial expertise in dermatology to develop best in class therapies against biologically validated targets. It is having  29 employees as on 2019. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share